Vaginal Atrophy News and Research

RSS
World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

Revolutionary treatment uses fat cells to correct vaginal and post-menopausal problems

Revolutionary treatment uses fat cells to correct vaginal and post-menopausal problems

Survey shows negative effect of vulvovaginal atrophy symptoms on quality of life for women

Survey shows negative effect of vulvovaginal atrophy symptoms on quality of life for women

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Post-menopausal Conversations: Why You Should Talk to Your Clinician

Post-menopausal Conversations: Why You Should Talk to Your Clinician

Maturitas provides new holistic model of care for healthy menopause

Maturitas provides new holistic model of care for healthy menopause

Multicenter trial compares popular treatments for menopause-related vaginal symptoms

Multicenter trial compares popular treatments for menopause-related vaginal symptoms

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Postmenopausal women who are not aware of VVA consequences continue to experience pain during sex

Postmenopausal women who are not aware of VVA consequences continue to experience pain during sex

VagiCap improves quality of life, satisfaction for postmenopausal women with vulvar and vaginal atrophy

VagiCap improves quality of life, satisfaction for postmenopausal women with vulvar and vaginal atrophy

Aeterna Zentaris signs strategic co-promotion services agreement with ASCEND

Aeterna Zentaris signs strategic co-promotion services agreement with ASCEND

New drug delivered through skin effective in treatment of breast cancer

New drug delivered through skin effective in treatment of breast cancer

vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

TherapeuticsMD's fourth quarter 2013 net revenue increases to $2.9 million

TherapeuticsMD's fourth quarter 2013 net revenue increases to $2.9 million

FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

British post-menopausal women less likely to access appropriate treatment for vaginal atrophy

British post-menopausal women less likely to access appropriate treatment for vaginal atrophy

Treatment can restore satisfying sex life post menopause

Treatment can restore satisfying sex life post menopause

Research findings provide new hope for people suffering from dry eye disease

Research findings provide new hope for people suffering from dry eye disease

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.